Decision-making on the value of pharmaceuticals | |
ā¢ Responsible Institution/Body | |
ā¢ Application area (remit) | |
ā¢ Evidence assessment | |
āāā production of evidence report | |
āāā assessment of evidence report | |
āāā assessment staff | |
ā¢ Evidence appraisal | |
āāā voting body and members | |
āāā term of office | |
ā¢ Re-Assessment | |
āāā Regular versus ad hoc | |
āāā Initiation (who/why) | |
Decision making on reimbursement and pricing of pharmaceuticals | |
ā¢ Responsible Institution / Body | |
ā¢ Restrictions |